OFFICIAL ROYAL PEPTIDES WEBSITE You are on royal-peptides.com
VERIFY OFFICIAL SITE

Royal Peptides

ROYAL RESEARCH CATALOG

KLOW 80mg Peptide Blend

Research Material Batch Documentation Secure Checkout
Price range: $75 through $650
Choose an option
Clear selection
BUY MORE • SAVE MORE Volume Pricing
Standard pricing
10+Shop Kits10-vial kits →
01Research focusedLaboratory research materials
02DocumentedAvailable batch information
03TrackedOrder fulfillment updates
Secure payment VISA link $ ₿
RESEARCH NOTICE
For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.
View Documentation →
Research Material • KLOW™ 80 mg

KLOW™ 80 mg Research Peptide Blend

KLOW™ is a four-component lyophilized research blend containing GHK-Cu, BPC-157, TB-500, and KPV in a defined 80 mg formulation, supplied by Royal Peptides exclusively for controlled laboratory, analytical, and scientific research.

4-Component Blend 80 mg Total Lyophilized Material Batch Traceability
Research Use Only

Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.

01
Blend Profile

KLOW™ Research Material

Royal Peptides KLOW™ is a defined multi-component research preparation combining four peptide materials in a single lyophilized vial.

Each vial contains a total of 80 mg of research material: 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV.

KLOW™ is supplied strictly as a laboratory research material. References to its individual components or scientific literature are provided solely for compound identification, analytical context, and research documentation.

02
Defined Composition

KLOW™ 80 mg Blend Composition

The KLOW™ formulation combines four separately identifiable research components at defined quantities within a single lyophilized research preparation.

GHK-Cu 50 mg Research peptide component
BPC-157 10 mg Research peptide component
TB-500 10 mg Research peptide component
KPV 10 mg Research tripeptide component
Total Research Material Per Vial 80 mg
03
Component Identification

Four-Component Research Formulation

Each component of KLOW™ is independently identifiable and has been referenced in scientific research literature. Their inclusion on this page is for identification and research context only.

GHK-Cu • 50 mg

A copper-binding peptide research material incorporated as the primary quantitative component of the KLOW™ formulation.

BPC-157 • 10 mg

Synthetic peptide research material included at a defined quantity within the four-component formulation.

TB-500 • 10 mg

Peptide research component incorporated into KLOW™ for controlled laboratory and analytical investigation.

KPV • 10 mg

Tripeptide research material incorporated at a defined 10 mg quantity within each KLOW™ research vial.

04
Research Environment

Controlled Multi-Component Research

KLOW™ is intended for appropriately controlled laboratory environments where defined multi-component peptide materials are required for analytical or experimental research workflows.

Analytical Characterization

Appropriate laboratory methods may be used to evaluate identity, composition, and other analytical characteristics of the research material.

Multi-Component Analysis

The defined formulation provides researchers with multiple identified peptide components within one research sample.

Comparative Research

Qualified laboratories may incorporate the material into appropriately designed comparative or reference-based experimental workflows.

Research Documentation

Product identification, lot information, and applicable analytical documentation support laboratory recordkeeping and material traceability.

05
Quality Documentation

Batch-Specific Analytical Information

Research materials should be evaluated using documentation associated with the specific production lot under investigation. General website information should not replace applicable batch-specific analytical documentation.

  • Product and blend identification
  • Production lot or batch reference
  • Component identification information
  • Analytical testing information
  • Purity information where applicable
  • Testing methodology where documented
  • Certificate of Analysis information where available
  • Research material traceability
06
Traceability

Research Records & Batch Control

Maintaining clear material records helps laboratories associate analytical observations with the specific KLOW™ production lot incorporated into an experimental workflow.

Material Identification

Record the KLOW™ product identifier, stated composition, applicable batch or lot reference, date received, and laboratory reference information.

Analytical Records

Preserve applicable COA information, analytical observations, laboratory results, storage records, and internal research documentation.

07
Laboratory Protocol

Handling & Storage

Professional Laboratory Handling

KLOW™ should be handled by personnel familiar with appropriate laboratory procedures, contamination control, research material identification, and laboratory safety practices.

Storage & Records

Researchers should follow storage information associated with the applicable product or batch documentation and maintain appropriate laboratory storage and material-control records.

08
Important Restrictions

What KLOW™ Is Not Intended For

Royal Peptides KLOW™ is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.

  • Not for human administration
  • Not for veterinary administration
  • Not for ingestion or injection
  • Not for personal experimentation
  • Not for pharmaceutical compounding
  • Not for pharmacy preparation
  • Not for diagnostic or therapeutic use
  • Not for clinical use
09
Research FAQ

KLOW™ Research Questions

What is KLOW™ 80 mg?

KLOW™ is a defined four-component lyophilized research blend supplied by Royal Peptides for controlled laboratory and analytical research.

What does KLOW™ contain?

Each vial contains 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV, for a total stated research-material content of 80 mg.

Is KLOW™ a single peptide?

No. KLOW™ is a multi-component research formulation containing four identified peptide materials within a single lyophilized research vial.

Is KLOW™ intended for human use?

No. Royal Peptides supplies KLOW™ strictly for laboratory research. It is not intended for human or veterinary administration.

Does Royal Peptides provide dosing instructions?

No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for KLOW™ or its individual research components.

Why is the batch number important?

Batch-specific analytical documentation corresponds to a particular production lot. Recording the applicable lot reference helps maintain traceability between the research material, supporting documentation, and laboratory records.

Is analytical documentation available?

Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.

Research Use Only

Laboratory Research Material

KLOW™ is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

0